Symbol="ADIL"
AssetType="Common Stock"
Name="Adial Pharmaceuticals Inc"
Description="Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia."
CIK="1513525"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4148000"
EBITDA="-13170611"
PERatio="None"
PEGRatio="None"
BookValue="1.262"
DividendPerShare="0"
DividendYield="0"
EPS="-11.44"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.922"
ReturnOnEquityTTM="-2.096"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-11.44"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="91.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.179"
EVToRevenue="-"
EVToEBITDA="-0.0585"
Beta="0.938"
num_52WeekHigh="15"
num_52WeekLow="3.13"
num_50DayMovingAverage="5.8"
num_200DayMovingAverage="7.59"
SharesOutstanding="1220000"
DividendDate="None"
ExDividendDate="None"
symbol="ADIL"
open="3.42"
high="3.51"
low="3.16"
price="3.43"
volume="51376.00"
latest_trading_day="2023-08-25"
previous_close="3.39"
change="0.04"
change_percent="1.1799%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="77"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="23"
Volume_recent_avg="1625059"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.71"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="23"
Aroon_momentum_negative="77"
image_negative_thumbnail_id_1="1086"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="560"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="658"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
